Cargando…
IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development
BACKGROUND: Insulin-like growth factor 1 (IGF-1) is a mitogenic hormone involved in many processes such as growth, metabolism, angiogenesis and differentiation. After very preterm birth, energy demands increase while maternal supplies of nutrients and other factors are lost and the infant may become...
Autores principales: | Hellström, Ann, Ley, David, Hallberg, Boubou, Löfqvist, Chatarina, Hansen-Pupp, Ingrid, Ramenghi, Luca A., Borg, Jan, Smith, Lois E. H., Hård, Anna-Lena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824464/ https://www.ncbi.nlm.nih.gov/pubmed/28969546 http://dx.doi.org/10.2174/1381612823666171002114545 |
Ejemplares similares
-
Insulin‐like growth factor 1 has multisystem effects on foetal and preterm infant development
por: Hellström, Ann, et al.
Publicado: (2016) -
IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants
por: Cakir, Bertan, et al.
Publicado: (2020) -
Unpasteurised maternal breast milk is positively associated with growth outcomes in extremely preterm infants
por: Lund, Anna‐My, et al.
Publicado: (2019) -
Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity
por: Hellgren, Gunnel, et al.
Publicado: (2017) -
Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity Among Preterm Infants
por: Sjöbom, Ulrika, et al.
Publicado: (2021)